Bio Techne Corporation Stock Price Today (NSE: TECH)

Bio Techne Corporation

34.290.19 (0.55%)
Market Open

Fundamental Score

...

Bio Techne Corporation Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Bio Techne Corporation share price today is 34.29, down 0.55% on NSE/BSE as of 5 August 2026. Bio Techne Corporation (TECH) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 80.63 (Cr). The 52-week high for TECH share price is 49.41 and the 52-week low is 28.00. At a P/E ratio of 29.64x, TECH is currently trading below its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 5.80% and a debt-to-equity ratio of 0.30.

Bio Techne Corporation Share Price Chart — NSE/BSE Historical Performance

No data
High
34.29
Low
28.00
Volume
1.4L
Change
+19.20%

Bio Techne Corporation share price chart: 19.20% return over the past month. 52-week high ₹49.41, 52-week low ₹28.00.

Bio Techne Corporation — Last 10 Trading Days

DateOpenHighLowCloseVolume
34.0034.0032.1633.6575.88K (Cr)
33.8134.2933.6533.912.99L (Cr)
32.5333.5632.5333.253.71L (Cr)
31.3732.3931.3732.2958.98K (Cr)
32.2032.2030.5031.3735.54K (Cr)
31.8232.2630.8631.7846.50K (Cr)
32.2932.3631.8731.971.35L (Cr)
31.7032.1731.6031.911.29L (Cr)
31.4131.7731.3531.471.27L (Cr)
31.9931.9931.3631.441.04L (Cr)

Bio Techne Corporation — Last 12 Months Price History

MonthOpenHighLowCloseChange
29.1934.2928.0033.65+15.28%
32.0134.1028.6529.01-9.37%
32.8534.1429.5231.86-3.01%
32.1635.3030.7032.05-0.34%
33.2333.9830.2231.50-5.21%
41.4842.7132.1233.15-20.08%
40.9249.4139.6741.11+0.46%
40.2243.4039.7340.83+1.52%
38.7740.5837.3440.10+3.43%
36.9039.4935.6938.34+3.90%
37.9739.9935.7035.91-5.43%
38.0538.8236.2537.52-1.39%

Returns & Performance

Poor

Return on Equity (ROE)

5.80%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.32%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

11.30%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Bio Techne Corporation Valuation Check

Average

Price to Earnings (P/E)

29.64x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

71.95%

% shares held by company founders/management

Poor

FII Holding

0.40%

% shares held by foreign institutional investors

Poor

DII Holding

1.13%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-20.86%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-5.75%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.30x

Total debt ÷ equity. Below 0.5 = financially healthy

Good

Interest Coverage Ratio

3.21x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-28.16 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Bio Techne Corporation Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TECH across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Conservative Debt Levels (D/E: 0.30)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Balanced Promoter Holding (71.95%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (5.80%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.32%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-20.86%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-5.75%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Negative Free Cash Flow (₹-28.16 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 1.53%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Bio Techne Corporation vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Bio Techne Corporation with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
19.4/100
34
₹80.63
29.6
Average
5.80%
Poor
6.32%
Poor
0.3
Excellent
0.00%
65.3/100
1611
₹159989.82
65.0
Average
23.92%
Excellent
31.02%
Excellent
0.0
Excellent
16.69%
Excellent
14.89%
Good
0.73%
42.9/100
4367
₹45440.05
77.3
Average
7.78%
Poor
9.86%
Poor
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
7568
₹39027.62
58.4
Average
20.26%
Excellent
21.37%
Excellent
0.3
Excellent
22.16%
Excellent
22.95%
Excellent
0.20%
32.8/100
1662
₹23159.08
41.4
Average
9.97%
Poor
11.49%
Average
0.3
Excellent
-6.33%
Poor
12.59%
Good
0.44%
36.3/100
1540
₹19624.13
86.7
Average
9.66%
Poor
11.92%
Average
0.2
Excellent
0.00%
38.7/100
489
₹18171.13
44.1
Average
7.13%
Poor
6.85%
Poor
0.8
Good
-4.67%
Poor
12.96%
Good
0.20%
Atul Ltd...
ATUL500027
58.2/100
6737
₹18051.49
26.6
Average
11.49%
Average
14.90%
Average
0.0
Excellent
1.26%
Average
10.95%
Good
0.49%
52.2/100
3634
₹16002.35
38.4
Average
10.92%
Average
14.68%
Average
0.0
Excellent
7.67%
Good
9.41%
Good
0.68%
62.09999999999999/100
4817
₹15713.17
38.1
Average
16.61%
Good
21.47%
Excellent
0.0
Excellent
27.91%
Excellent
15.86%
Excellent
0.21%
33.3/100
1208
₹14449.70
84.9
Average
5.50%
Poor
7.36%
Poor
0.6
Good
19.29%
Excellent
23.88%
Excellent
0.06%

Bio Techne Corporation Quarterly Performance

Latest quarterly metrics for TECH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-5.75%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-20.86%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Bio Techne Corporation Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TECH — calculated from daily price history

75RSI 14
Overbought — RSI 75

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
31
▲ Price above SMA 50 — Short-term bullish
SMA 200
35
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
122K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Bio Techne Corporation Financial Statements

Annual income statement, balance sheet and cash flow for Bio Techne Corporation (TECH) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Bio Techne Corporation

About TECH (Bio Techne Corporation)

Bio Techne Corporation (TECH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a... current market capitalisation of ₹80.63 (Cr). Bio Techne Corporation has delivered a Return on Equity (ROE) of 5.80% and a ROCE of 6.32%. The debt-to-equity ratio stands at 0.30, reflecting the company's capital structure. Investors tracking TECH share price can monitor key metrics including P/E ratio, promoter holding of 71.95%, and quarterly earnings growth.

Company Details

Symbol:TECH
Industry:Specialty Chemicals
Sector:Specialty Chemicals
Website:N/A

TECH Share Price: Frequently Asked Questions

What is the current share price of Bio Techne Corporation?

Bio Techne Corporation (TECH) trades at ₹34.29 on NSE and BSE. Market cap ₹80.63 (Cr). Educational data only.

What is the P/E ratio of Bio Techne Corporation?

Bio Techne Corporation has a P/E of 29.64x vs industry average 31.95x.

What is the Bull Run score for Bio Techne Corporation?

Bio Techne Corporation has a Bull Run score of 19.4/100 based on 25+ financial parameters.

Does Bio Techne Corporation pay dividends?

Bio Techne Corporation has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Bio Techne Corporation?

Bio Techne Corporation has ROE of 5.80%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Bio Techne Corporation?

Bio Techne Corporation has debt-to-equity of 0.30.

Is Bio Techne Corporation a good investment?

Bull Run gives Bio Techne Corporation a score of 19.4/100. This is not investment advice — consult a SEBI-registered advisor.